Latest clinical trials have indicated favorable outcomes following transcatheter aortic valve
replacement (TAVR) in low surgical risk patients with severe aortic stenosis. However, there …

Transcatheter aortic valve replacement (TAVR) is a transformative innovation that provides
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …

The results of the Placement of AoRtic TraNscathetER Valves (PARTNER) 2 trial established
the feasibility of transcatheter aortic valve replacement (TAVR) for intermediate surgical risk …

Transcatheter aortic valve replacement (TAVR) has become the preferred treatment in
patients with symptomatic severe aortic stenosis deemed to be at prohibitive or high risk for …

Transcatheter aortic valve replacement (TAVR) is the predominate treatment for severe
aortic stenosis, and initial valve selection and lifetime management has become …

Aortic stenosis (AS) is the most common cardiac valve disease in developed countries.
Transcatheter aortic valve replacement (TAVR) for the treatment of severe symptomatic AS is …

Based on randomized clinical trials and observational registries, transcatheter aortic valve
replacement (TAVR) has become a valuable therapeutic option for patients with …

coronary intervention(PCI) and transcatheter aortic valve replacement (TAVR) have started
at the antipodes of the risk spectrum. Although the former was established in low-risk …

During the last decade transcatheter aortic valve replacement (TAVR) has been established
as a treatment for patients with severe aortic stenosis, who are at particularly high surgical …

Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic
stenosis, thus changing the treatment options for patients. TAVR is currently approved for …